Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making

Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making

Abstract Background In recent years, compounded bioidentical hormone therapy (CBHT) has emerged as a popular alternative to manufactured, FDA approved hormone therapy (HT)—despite concerns within the medical community and the availability of new FDA approved “bioidentical” products. This study aims...

Full description

Bibliographic Details
Main Authors: Jennifer Jo Thompson, Cheryl Ritenbaugh, Mark Nichter
Format: Article
Language:English
Published: BMC 2017-10-01
Series:BMC Women's Health
Subjects:
Menopause
Hormone therapy
Bioidentical hormones
Compounded hormones
Shared decision-making
Qualitative research
Online Access:http://link.springer.com/article/10.1186/s12905-017-0449-0

Internet

http://link.springer.com/article/10.1186/s12905-017-0449-0

Similar Items